Delivery Order SPE2DB24D2013-SPE2DB25FCKAQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,026.53 on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units). This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The delivery order is set to be completed by September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units, with a ceiling value of $8,026.53 and a firm fixed price structure. This award represents a non-set-aside competitive procurement that will be performed at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $12,029.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a continuation of the company's pharmaceutical supply services to the federal government. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units, with a ceiling value of $4,418.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-unit packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Promacta 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $16,053.06 and an ultimate completion date of August 26, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,029.63, with an ultimate completion date of August 20, 2025. The contract is not set-aside and represents a competitively awarded procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $13.3K for the supply of Promacta 12.5 mg tablets (30-count units) with delivery completion required by August 20, 2025. The award utilizes firm fixed price terms under a non-competitive set-aside arrangement and is performed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKAQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This award, valued at $16,053.06, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The contract is scheduled for ultimate completion by September 18, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that supports global military healthcare programs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical medical supply partner for federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. Promacta (eltrombopag) is an immunosuppressant medication used in the treatment of thrombocytopenia and other hematologic conditions. The company's extensive federal contract portfolio demonstrates its established capability to fulfill pharmaceutical procurement requirements across multiple therapeutic domains through competitive procurement processes, positioning it as a strategic vendor for military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 8/27/25 |